Joseph Mıkhael - Publications, H-index & Citations

Joseph Mıkhael

City of Hope Cancer Center

62H指数

378论文数

1.5W被引数

收录论文 81

发表时间

REVEAL-MM: retrospective evaluation of variables in early assessment and landmark trends in multiple myeloma—a US claims-based case-control study REVEAL-MM：多发性骨髓瘤早期评估和里程碑趋势中变量的回顾性评估——一项基于美国索赔数据的病例对照研究

Blood Cancer Journal

IF11.6

2026-09-14

OAAI

Faith E. Davies; Beth Faiman; Hayley Beer; Anne Quinn Young; Katie Joyner; Kate Morgan; Stephen Huo; J. Blake Bartlett; Yi Han; Georgia Attfield; Daniel Egbase; Joseph Mikhael

An Equity-Embedded, Protocol-Agnostic Pre-Trial Navigation Model for Canadian Blood Cancer Trials: Findings from the Myeloma Canada Phase 0 Workshop 一个嵌入公平性、协议无关的加拿大血液肿瘤临床试验预试验导航模型：来自Myeloma Canada第0阶段研讨会的发现

Current Oncology

IF3.4

2026-08-24

OAAI

Gabriele Colasurdo; Alvina Nadeem; Nina Mason; Juliette Royer; Stephanie Soltys; Henry Chan; Richard K. Plante; Julie Stakiw; Joseph R. Mikhael; Michelle Oana

Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions Isatuximab在多发性骨髓瘤治疗中的应用：当前临床进展与未来方向

Expert Opinion on Investigational Drugs

IF4.1

2025-07-23

OAAI

Paul G. Richardson; Elisabeth K. O’Donnell; Peter O’Gorman; Lisa B. Leypoldt; Jacob Laubach; Francesca Gay; Xavier Leleu; Thierry Facon; Philippe Moreau; Meletios A. Dimopoulos; Hartmut Goldschmidt; Elias K. Mai; Michele Cavo; Katja C. Weisel; Jesus G. Berdeja; Robert Z. Orlowski; Meral Beksaç; Aurore Perrot; Joseph Mikhael; Thomas Martin

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma 基于卡非佐米的四联体组合作为新诊断多发性骨髓瘤治疗的当前和未来作用

HemaSphere

IF14.6

2025-07-16

OAAI

Ola Landgren; Noa Biran; Elizabeth K. O'Donnell; Joseph Mikhael; Katja C. Weisel; Annemiek Broijl; Saad Z. Usmani; Philippe Moreau; Francesca M. Gay

The benefits of telehealth in promoting equity in blood cancer care - results of a multi-stakeholder forum and systematic literature review 远程医疗在促进血液肿瘤护理公平性方面的益处——多利益相关方论坛和系统文献综述的结果

JOURNAL OF MEDICAL ECONOMICS

IF3

2025-05-27

OAAI

Joseph Mikhael; Deanna Darlington; Bethany Howell; Jay Hydren; Tricia Hernandez; Sally Werner; Tracey Iraca; Mary Arnett; Victor Gonzalez; Susan Peschin; Alan J. Balch; Diane Moran; Roslyn Young-Daniels; Olamide Banjo; George Dennis Obeng; Benjamin Asiedu-Ayeh; Sampson Kawuo; Asmau Mohammed Tukur; Inusah Mohammed; Akosua Pokuaah Obeng; Marcell Csanádi; Thomas Lew; Mimi Choon-Quinones

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

BLOOD CANCER JOURNAL

IF11.6

2024-11-28

OAAI

Richardson, Paul G.; Perrot, Aurore; Mikhael, Joseph; Martin, Thomas; Beksac, Meral; Spicka, Ivan; Capra, Marcelo; D'Agostino, Mattia; Sonneveld, Pieter; Bisht, Kamlesh; Fukao, Taro; Zhang, Rick; Tada, Keisuke; Tekle, Christina; Mace, Sandrine; Klippel, Zandra; van de Velde, Helgi; Moreau, Philippe

Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative 推进以患者为中心的护理以克服多发性骨髓瘤中的健康差异：一项质量改进倡议的关键发现

BLOOD

IF23.1

2024-11-05

PREAI

Mikhael, Joseph; Rodriguez, Cesar; Pierre, Amy E.; Nawaz, M. Sarfraz; Moses-Okwei, Ellie; Gurska, Lindsay; Zyborowicz, Emily; Sullivan, Shelby; Carter, Jeffrey; Heggen, Cherilyn

Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial

LANCET HAEMATOLOGY

IF17.7

2024-10-01

PREAI

Yong, Kwee; Martin, Thomas; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Spicka, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Casca, France; Mace, Sandrine; Risse, Marie-Laure; Moreau, Philippe

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study

HEMATOLOGICAL ONCOLOGY

IF3.9

2024-02-25

OAAI

Facon, Thierry; Moreau, Philippe; Spicka, Ivan; Suzuki, Kenshi; Yong, Kwee; Mikhael, Joseph; Fukao, Taro; Bisht, Kamlesh; Armstrong, Nicole M.; Mace, Sandrine; Risse, Marie-Laure; Martin, Thomas

Addressing the disparities: the approach to the African American patient with multiple myeloma

BLOOD CANCER JOURNAL

IF11.6

2023-12-18

OAAI

Bhutani, Manisha; Blue, Brandon J.; Cole, Craig; Badros, Ashraf Z.; Usmani, Saad Z.; Nooka, Ajay K.; Bernal-Mizrachi, Leon; Mikhael, Joseph

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study (vol 13, 152, 2023)

BLOOD CANCER JOURNAL

IF11.6

2023-09-27

OAAI

Martin, Thomas; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Spicka, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Casca, France; Mace, Sandrine; Risse, Marie-Laure; Moreau, Philippe

Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma

BLOOD CANCER JOURNAL

IF11.6

2023-05-30

OAAI

Banerjee, Rahul; Williams, Louis; Mikhael, Joseph R.

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (vol 13, 32, 2023)

BLOOD CANCER JOURNAL

IF11.6

2023-05-26

OAAI

Fonseca, Rodrigo; Arribas, Mariano; Wiedmeier-Nutor, Julia E. E.; Kusne, Yael N. N.; Velez, Miguel Gonzalez; Kosiorek, Heidi E. E.; Butterfield, Richard (Duke) J.; Kirsch, Ilan R. R.; Mikhael, Joseph R. R.; Stewart, A. Keith; Reeder, Craig; Larsen, Jeremy; Bergsagel, P. Leif; Fonseca, Rafael

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

BLOOD CANCER JOURNAL

IF11.6

2023-05-09

OAAI

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

BLOOD CANCER JOURNAL

IF11.6

2023-03-06

OAAI

Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior Transplantation

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2023-02-01

OAAI

Martin, Thomas G.; Capra, Marcelo; Mohty, Mohamad; Suzuki, Kenshi; Quach, Hang; Cavo, Michele; Moreau, Philippe; Dimopoulos, Meletios; Yong, Kwee; Tekle, Christina; Foster, Meredith C.; Barnes, Yvonne; Risse, Marie-Laure; Mikhael, Joseph

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma

BLOOD ADVANCES

IF7.1

2022-08-03

OAAI

Martin, Thomas; Mikhael, Joseph; Hajek, Roman; Kim, Kihyun; Suzuki, Kenshi; Hulin, Cyrille; Garg, Mamta; Quach, Hang; Sia, Hanlon; George, Anup; Konstantinova, Tatiana; Risse, Marie-Laure; Asset, Gaelle; Mace, Sandrine; van de Velde, Helgi; Moreau, Philippe

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2022-06-04

OAAI

Dimopoulos, Meletios A.; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez-Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie-Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

BLOOD CANCER DISCOVERY

IF11.5

2022-06-02

OAAI

Davies, Faith E.; Pawlyn, Charlotte; Usmani, Saad Z.; San-Miguel, Jesus F.; Einsele, Hermann; Boyle, Eileen M.; Corre, Jill; Auclair, Daniel; Cho, Hearn Jay; Lonial, Sagar; Sonneveld, Pieter; Stewart, A. Keith; Bergsagel, P. Leif; Kaiser, Martin F.; Weisel, Katja; Keats, Jonathan J.; Mikhael, Joseph R.; Morgan, Kathryn E.; Ghobrial, Irene M.; Orlowski, Robert Z.; Landgren, C. Ola; Gay, Francesca; Caers, Joseph; Chng, Wee Joo; Chari, Ajai; Walker, Brian A.; Kumar, Shaji K.; Costa, Luciano J.; Anderson, Kenneth C.; Morgan, Gareth J.

VP5-2022: Updated progression-free survival (PFS) and depth of response in IKEMA, a randomized phase III trial of isatuximab, carfilzomib and dexamethasone (Isa-Kd) vs Kd in relapsed multiple myeloma (MM)

ANNALS OF ONCOLOGY

IF65.4

2022-06-01

OAAI

Moreau, P.; Dimopoulos, M. A. C.; Mikhael, J.; Yong, K.; Capra, M.; Facon, T.; Hajek, R.; Spicka, I.; Casca, F.; Mace, S.; Singh, E.; Risse, M-L.; Martin, T.

研究方向